Paper41454271
Monocyte-to-lymphocyte ratio as an inflammatory biomarker for predicting diabetic peripheral neuropathy in type 2 diabetes mellitus patients.
Li J and 5 others. BMC Endocr Disord, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Monocyte-to-lymphocyte ratio as an inflammatory biomarker for predicting diabetic peripheral neuropathy in type 2 diabetes mellitus patients. Papers, record 41454271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41454271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Monocyte-to-lymphocyte ratio as an inflammatory biomarker for predicting diabetic peripheral neuropathy in type 2 diabetes mellitus patients.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Neuropathies | Major topic |
| Biomarkers | Major topic |
| Lymphocytes | Major topic |
| Monocytes | Major topic |
| Inflammation | Major topic |
| Humans | |
| Male | |
| Female | |
| Middle Aged | |
| Aged | |
| Prognosis | |
| Follow-Up Studies | |
| Adult | |
| Neural Conduction |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27979889 | 2. Classification and Diagnosis of Diabetes. | Diabetes Care | 2017 | https://conductscience.org/library/papers/27979889 | PubMed |
| 2 | 37573470 | Prognostic value of monocyte-to-lymphocyte ratio for 90-day all-cause mortality in type 2 diabetes mellitus patients with chronic kidney disease. | Sci Rep | 2023 | https://conductscience.org/library/papers/37573470 | PubMed |
| 3 | 34639176 | Inflammatory Mechanisms in the Pathophysiology of Diabetic Peripheral Neuropathy (DN)-New Aspects. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34639176 | PubMed |
| 4 | 3717907 | The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. | Ann Neurol | 1986 | https://conductscience.org/library/papers/3717907 | PubMed |
| 5 | 26897744 | Inflammation as a Therapeutic Target for Diabetic Neuropathies. | Curr Diab Rep | 2016 | https://conductscience.org/library/papers/26897744 | PubMed |
| 6 | 27189025 | Type 2 diabetes mellitus. | Nat Rev Dis Primers | 2015 | https://conductscience.org/library/papers/27189025 | PubMed |
| 7 | 36142551 | Circulating Biomarkers of Endothelial Dysfunction and Inflammation in Predicting Clinical Outcomes in Diabetic Patients with Critical Limb Ischemia. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142551 | PubMed |
| 8 | 38655656 | Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study. | Acta Derm Venereol | 2024 | https://conductscience.org/library/papers/38655656 | PubMed |
| 9 | 29277966 | Role of inflammatory biomarkers in diabetic peripheral neuropathy. | J Diabetes Investig | 2018 | https://conductscience.org/library/papers/29277966 | PubMed |
| 10 | 37795833 | How inflammation dictates diabetic peripheral neuropathy: An enlightening review. | CNS Neurosci Ther | 2024 | https://conductscience.org/library/papers/37795833 | PubMed |
| 11 | 29565290 | Role of Inflammation in Diabetic Retinopathy. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29565290 | PubMed |
| 12 | 21695763 | Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. | Diabetes Metab Res Rev | 2011 | https://conductscience.org/library/papers/21695763 | PubMed |
| 13 | 22271716 | Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy. | Diabetes Metab Res Rev | 2012 | https://conductscience.org/library/papers/22271716 | PubMed |
| 14 | 25273317 | Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment. | Endocrine | 2015 | https://conductscience.org/library/papers/25273317 | PubMed |
| 15 | 26308022 | Use of the Monocyte-to-Lymphocyte Ratio to Predict Diabetic Retinopathy. | Int J Environ Res Public Health | 2015 | https://conductscience.org/library/papers/26308022 | PubMed |
| 16 | 29610062 | Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review. | Diabetes Metab Syndr | 2018 | https://conductscience.org/library/papers/29610062 | PubMed |
| 17 | 22608666 | Diabetic neuropathy: clinical manifestations and current treatments. | Lancet Neurol | 2012 | https://conductscience.org/library/papers/22608666 | PubMed |
| 18 | 31197153 | Diabetic neuropathy. | Nat Rev Dis Primers | 2019 | https://conductscience.org/library/papers/31197153 | PubMed |
| 19 | 31057114 | Microvascular Complications of Type 2 Diabetes Mellitus. | Curr Vasc Pharmacol | 2020 | https://conductscience.org/library/papers/31057114 | PubMed |
| 20 | 29581246 | The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis. | Biosci Rep | 2018 | https://conductscience.org/library/papers/29581246 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41454271
GET https://conductscience.org/api/papers/v1/41454271/references?page=2